Table 3.
Evaluation method | Features |
---|---|
Radiograph (n = 9) | Vague sclerosis (n = 5) |
Marked sclerosis (n = 1) | |
Invisible (n = 3) | |
Bone scintigram (n = 2) | No abnormal uptake (n = 2) |
CT scan (n = 7) | Osteosclerosis in vertebral body (n = 7) |
No bone destruction or cortical disruption (n = 7) | |
MRI (n = 8) | T1-WI (n = 8): low signal intensity |
T2-WI (n = 8): intermediate–high signal intensity | |
Gd-DTPA T1-WI (n = 3): no enhancement | |
No invasive soft tissue mass (n = 8) | |
Histology (n = 8) | Solid sheets of adipocyte-like vacuolated cells combined with less vacuolated eosinophilic cells of various degrees |
Round or polygonal pyknotic nuclei occasionally with polymorphism | |
No lobular configuration | |
No extracellular myxoid matrix | |
Some cystic spaces containing eosinophilic colloid-like material | |
No mitotic figures | |
Poor vascular network | |
Entrapped islands of hematopoietic bone marrow | |
Sclerotic bone trabeculae affected | |
Positive immunostaining for vimentin, cytokeratin (AE1/AE3, CK18), EMA, and S-100 protein |
CT, computed tomography; MR, magnetic resonance; WI, weighted image; Gd; gadolinium; CK, cytokeratin; EMa, epithelial membrane antigen.